Abstract C011: Discovery of novel SMARCA2 small molecule inhibitors with best-in-class potency and selectivity for the treatment of SMARCA4-mutant cancers
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: Galapagos (Belgium)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444844
Cites:
Cited by:
Related to:
